(19)
(11) EP 1 206 293 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
30.08.2006 Bulletin 2006/35

(45) Mention of the grant of the patent:
05.07.2006 Bulletin 2006/27

(21) Application number: 00959377.3

(22) Date of filing: 24.08.2000
(51) International Patent Classification (IPC): 
A61L 27/50(2006.01)
(86) International application number:
PCT/US2000/023295
(87) International publication number:
WO 2001/013972 (01.03.2001 Gazette 2001/09)

(54)

HOMOPOLYMERS CONTAINING CROSSLINKERS AND OCULAR IMPLANTS MADE THEREFROM

HOMOPOLYMERE ENTHALTENDE VERNETZER UND DARAUS HERGESTELLTES OKULARES IMPLANTAT

HOMOPOLYMERES CONTENANT DES AGENTS DE RETICULATION ET IMPLANTS OCULAIRES PRODUITS A PARTIR DE CEUX-CI

(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 26.08.1999 US 383837

(43) Date of publication of application:
22.05.2002 Bulletin 2002/21

(73) Proprietor: IOLTECH
17180 Perigny (FR)

(72) Inventors:
  • LIAO, Xiuago
    Irvine, CA 92606 (US)
  • GULATI, Vijay
    Lake Forest, CA 92630 (US)

(74) Representative: Santarelli 
14, avenue de la Grande Armée, B.P. 237
75822 Paris Cedex 17
75822 Paris Cedex 17 (FR)


(56) References cited: : 
WO-A-96/40303
US-A- 5 821 306
 US-A- 5 674 960
US-A- 5 891 931
   
  • "WEBSTER'S THIRD NEW INTERNATIONAL DICTIONARY" 1993, MERRIAM-WEBSTER, INCORPORATED
  • [Online] Etherington & Roberts Dictionary, a Dictionary of Descriptive Terminology Retrieved from the Internet: URL:http://palimpsest.stanford.edu/don/dt/ dt1549.html>
  • PATENT ABSTRACTS OF JAPAN vol. 010, no. 355 (C-388) 29 November 1986 & JP 61 152 711 A (KUREHA CHEMICAL IND CO LTD) 11 July 1986
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).